SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended October 31, 2004 or
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
0-21488
(Commission File Number)
CATALYST SEMICONDUCTOR, INC.
| Delaware (State or other jurisdiction of incorporation or organization) |
77-0083129 (I.R.S. Employer Identification No.) |
|
| 1250 Borregas Avenue Sunnyvale, California (Address of Registrants principal executive offices) |
94089 (Zip Code) |
(408) 542-1000
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12(b)(2) of the Exchange Act). Yes x No o
The number of shares outstanding of the Registrants Common Stock as of November 29, 2004 was 18,231,294 exclusive of 3,678,363 shares of treasury stock.
CATALYST SEMICONDUCTOR, INC.
TABLE OF CONTENTS
| Page |
||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 6 | ||||||||
| 14 | ||||||||
| 33 | ||||||||
| 33 | ||||||||
| 34 | ||||||||
| 34 | ||||||||
| 34 | ||||||||
| 35 | ||||||||
| EXHIBIT 31.1 | ||||||||
| EXHIBIT 31.2 | ||||||||
| EXHIBIT 32 | ||||||||
2
PART I. Financial Information
CATALYST SEMICONDUCTOR, INC.
| October 31, |
April 30, |
|||||||
| 2004 |
2004 |
|||||||
| (In thousands) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 7,094 | $ | 17,245 | ||||
Short term investments |
35,844 | 16,564 | ||||||
Accounts receivable, net |
9,561 | 12,547 | ||||||
Inventories |
10,311 | 6,960 | ||||||
Deferred tax assets |
5,024 | 5,024 | ||||||
Other current assets |
870 | 875 | ||||||
Total current assets |
68,704 | 59,215 | ||||||
Property and equipment, net |
5,590 | 3,334 | ||||||
Deferred tax assets |
4,098 | 4,098 | ||||||
Other assets |
159 | 218 | ||||||
Total assets |
$ | 78,551 | $ | 66,865 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 4,775 | $ | 4,879 | ||||
Accounts payable related parties |
140 | 137 | ||||||
Accrued expenses |
4,641 | 3,782 | ||||||
Deferred gross profit on shipments to distributors |
2,967 | 4,079 | ||||||
Total current liabilities |
12,523 | 12,877 | ||||||
Commitments and contingencies (Note 8) |
||||||||
Stockholders equity: |
||||||||
Preferred stock, $.001 par value, 2,000 shares authorized; no shares issued and outstanding |
| | ||||||
Common stock, $.001 par value, 45,000 shares authorized; 21,909 shares issued and 18,231
shares outstanding at October 31, 2004 and 20,057 shares issued and 16,413 shares
outstanding at April 30, 2004 |
22 | 20 | ||||||
Additional paid-in-capital |
68,284 | 59,228 | ||||||
Treasury stock, 3,678 shares at October 31, 2004 and 3,644 shares at April 30, 2004 |
(12,796 | ) | (12,616 | ) | ||||
Retained earnings |
10,580 | 7,382 | ||||||
Accumulated other comprehensive loss |
(62 | ) | (26 | ) | ||||
Total stockholders equity |
66,028 | 53,988 | ||||||
Total liabilities and stockholders equity |
$ | 78,551 | $ | 66,865 | ||||
See accompanying notes to the unaudited condensed consolidated financial statements.
3
CATALYST SEMICONDUCTOR, INC.
| Three Months Ended October 31, |
Six Months Ended October 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (In thousands, except per share data) | ||||||||||||||||
Net revenues |
$ | 15,604 | $ | 15,978 | $ | 32,315 | $ | 29,825 | ||||||||
Cost of revenues |
9,244 | 10,987 | 17,280 | 19,687 | ||||||||||||
Gross profit |
6,360 | 4,991 | 15,035 | 10,138 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
1,932 | 1,650 | 4,075 | 3,198 | ||||||||||||
Selling, general and administrative |
3,392 | 2,924 | 6,550 | 5,531 | ||||||||||||
Income from operations |
1,036 | 417 | 4,410 | 1,409 | ||||||||||||
Interest income, net |
184 | 84 | 293 | 174 | ||||||||||||
Income before income taxes |
1,220 | 501 | 4,703 | 1,583 | ||||||||||||
Income tax provision |
216 | 75 | 1,505 | 237 | ||||||||||||
Net income |
$ | 1,004 | $ | 426 | $ | 3,198 | $ | 1,346 | ||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | 0.06 | $ | 0.03 | $ | 0.18 | $ | 0.08 | ||||||||
Diluted |
$ | 0.05 | $ | 0.02 | $ | 0.16 | $ | 0.07 | ||||||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic |
18,221 | 16,483 | 17,490 | 16,421 | ||||||||||||
Diluted |
19,978 | 19,407 | 19,494 | 19,081 | ||||||||||||
See accompanying notes to the unaudited condensed consolidated financial statements.
4
CATALYST SEMICONDUCTOR, INC.
| Six Months Ended October 31, |
||||||||
| 2004 |
2003 |
|||||||
| (In thousands) | ||||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 3,198 | $ | 1,346 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation of property and equipment |
769 | 560 | ||||||
Benefit from sale of inventory previously written down |
(559 | ) | (1,365 | ) | ||||
Provision for excess and obsolete inventory |
521 | 594 | ||||||
Loss on disposal of fixed assets |
235 | | ||||||
Tax benefit of options |
607 | | ||||||
Changes in assets and liabilities: |
||||||||
Accounts receivable |
2,986 | (3,507 | ) | |||||
Inventories |
(3,313 | ) | 2,960 | |||||
Other assets |
64 | 319 | ||||||
Accounts payable (including related parties) |
(101 | ) | 294 | |||||
Accrued expenses |
859 | 941 | ||||||
Deferred gross profit on shipments to distributors |
(1,112 | ) | 681 | |||||
Net cash provided by operating activities |
4,154 | 2,823 | ||||||
Cash flows from investing activities: |
||||||||
Purchases of short-term investments |
(39,961 | ) | (12,419 | ) | ||||
Proceeds from sales and maturities of short-term investments |
20,645 | 6,209 | ||||||
Acquisition of property and equipment |
(3,260 | ) | (688 | ) | ||||
Net cash used in investing activities |
(22,576 | ) | (6,898 | ) | ||||
Cash flows from financing activities: |
||||||||
Common stock issuances from exercise of options |
465 | 522 | ||||||
Net proceeds from secondary offering |
7,986 | | ||||||
Treasury stock purchases |
(180 | ) | (215 | ) | ||||
Net cash provided by financing activities |
8,271 | 307 | ||||||
Net decrease in cash and cash equivalents |
(10,151 | ) | (3,768 | ) | ||||
Cash and cash equivalents at beginning of the period |
17,245 | 7,828 | ||||||
Cash and cash equivalents at end of the period |
$ | 7,094 | $ | 4,060 | ||||
See accompanying notes to the unaudited condensed consolidated financial statements.
5
CATALYST SEMICONDUCTOR, INC.
Note 1 Basis of Presentation:
Catalyst Semiconductor, Inc. (the Company), was founded in October 1985, and designs, develops and markets a broad line of reprogrammable non-volatile memory and analog/mixed-signal products.
In the opinion of the management of the Company, the unaudited condensed consolidated interim financial statements included herein have been prepared on the same basis as the Companys April 30, 2004 audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. For further information, refer to the consolidated financial statements and footnotes thereto included in the Companys Annual Report on Form 10-K for the year ended April 30, 2004, as amended. Certain prior period balances have been reclassified to conform to the current period presentation.
The Companys fiscal year is the 52 or 53-week period ending on the Sunday closest to April 30. The Company refers to the fiscal year ended April 27, 2003 as fiscal 2003, the fiscal year ended May 2, 2004 as fiscal 2004 and the fiscal year ending May 1, 2005 as fiscal 2005. In a 52-week year, each fiscal quarter consists of 13 weeks. Fiscal year 2004 was comprised of 53 weeks with the extra week added to the third quarter making it consist of 14 weeks. Fiscal year 2005 will be comprised of 52 weeks. For presentation purposes only, the financial statements and notes refer to April 30 as the Companys fiscal year end and July 31, October 31 and January 31 as the end of the Companys fiscal quarters.
Principles of Consolidation
The consolidated financial statements include the accounts of Catalyst Semiconductor, Inc. and its wholly owned subsidiaries, Nippon Catalyst KK (NCKK), a sales organization in Japan, and Catalyst Semiconductor Romania SRL (CSR), a product development center in Bucharest, Romania. All significant intercompany accounts and transactions are eliminated in consolidation.
Uses of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles in the United States (US GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates in these financial statements include inventory valuation, deferral of distributor inventory not sold at the end of the period, reserves for stock rotation on sales to distributors, the original equipment manufacturers (OEMs) sales return reserve, allowances for doubtful accounts receivable and income taxes. Actual results could differ from those estimates.
Stock-Based Compensation
The Company has elected to measure employee stock-based compensation costs using the intrinsic value method prescribed by the Accounting Principles Board Opinion (ABP) No. 25, Accounting for Stock Issued to Employees and to comply with the pro forma disclosure requirements of Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation. Stock-based compensation to employees under SFAS No. 123 is based on the fair value of the option, estimated using the Black-Scholes Option Pricing Model on the date of grant. The related stock-based compensation expense is recognized over the vesting period.
6
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The following table illustrates the effect on net income and net income per share if the Company had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation:
| Three Months Ended October 31, |
Six Months Ended October 31, |
||||||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
||||||||||||||||
| (In thousands, except per share amounts) | |||||||||||||||||||
Reported net income |
$ | 1,004 | $ | 426 | $ | 3,198 | $ | 1,346 | |||||||||||
Deduct: Stock-based
employee compensation
expense determined under
fair value based method for
all awards, net of tax |
(510 | ) | (673 | ) | (1,112 | ) | (1,421 | ) | |||||||||||
Pro forma net income (loss) |
$ | 494 | $ | (247 | ) | $ | 2,086 | $ | (75 | ) | |||||||||
Net income (loss) per share: |
|||||||||||||||||||
Basic as reported |
$ | 0.06 | $ | 0.03 | $ | 0.18 | $ | 0.08 | |||||||||||
Basic pro forma |
$ | 0.03 | $ | (0.01 | ) | $ | 0.12 | $ | 0.00 | ||||||||||
Diluted reported |
$ | 0.05 | $ | 0.02 | $ | 0.16 | $ | 0.07 | |||||||||||
Diluted pro forma |
$ | 0.02 | $ | (0.01 | ) | $ | 0.11 | $ | 0.00 | ||||||||||
Note 2 Significant Accounting Policies
Cash and Cash Equivalents
All highly liquid investments held with a remaining maturity of three months or less are considered cash equivalents.
Short-term Investments
All of the Companys short-term investments are classified as available-for-sale. Investments in available-for-sale securities are reported at fair value with unrealized gains and losses, net of related tax, as a component of accumulated other comprehensive income (loss). Refer to Note 4 for details related to available-for-sale securities.
Fair Value of Financial Instruments
The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For financial instruments, including cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued expenses, the carrying amounts approximate fair value due to their short maturities.
Foreign Currency Translation
The Company uses the U.S. dollar as its functional currency. All of the Companys sales and a substantial majority of its costs are transacted in U.S. dollars. The Company purchases wafers from Japan, has test and assembly activities in Thailand and supports sales and marketing activities in various countries outside of the United States. Most of these costs are paid for with U.S. dollars. The research and development personnel costs in Romania are tracked against the euro while all other activities are paid in Romanian leu. Foreign currency transaction gains and losses, resulting from remeasuring local currency to the U.S. dollar, are included in determining net income for the period. They were not material for the periods presented.
Recognition of Revenues
The Company generally recognizes revenues as products are shipped if evidence of an arrangement exists, the customer has taken title to the products, services, if any, have been rendered, the sales price is fixed or determinable, collection of the resulting receivable is reasonably assured and product returns are reasonably estimable.
The Company markets and sells products directly through our sales force and sales representatives to original equipment manufacturers (OEM) and indirectly through distributors and resellers. Revenues are recognized upon delivery to OEMs and resellers who have no, or limited, product return rights and no price protection rights. Reserves for estimated returns and allowances are provided against net revenues at the time of recognition of revenues. The Company also sells products to certain distributors under agreements which allow certain rights to return the product and price protection rights. These agreements generally permit the distributor to return up to 10%, by value, of the total products they purchased from the Company every six months. As a result of the
7
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
above, the Company defers recognition of revenues until the time the distributor sells the product to an end-customer. Upon shipment to a distributor, the Company records an accounts receivable from the distributor, relieves inventory for the cost of the product shipped, and records the gross profit, revenues less the cost of revenues, on the consolidated balance sheet as deferred gross profit on shipments to distributors until the inventory is resold by the distributor.
Inventories
Inventory is stated at the lower of standard cost or net realizable value. Standard cost approximates actual cost on a first-in, first-out basis. The Company periodically reviews its inventory for slow moving or obsolete items and writes down the related products to estimated net realizable value.
Shipping and Handling Costs
The Company charges internal freight shipments within the supply chain and associated handling costs to the cost of revenues on its consolidated statement of operations. The Company charges outbound freight shipments and associated handling costs to selling, general and administrative on its consolidated statement of operations. Such outbound freight costs aggregated to $159,000 and $139,000 for the three months ended October 31, 2004 and 2003, respectively and to $313,000 and $317,000 for the six months ended October 31, 2004 and 2003, respectively.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. Furniture, office equipment and engineering/test equipment are depreciated over five years. Computer hardware and software is depreciated over either three or five years. Buildings are generally depreciated over 30 years. Amortization of leasehold improvements is computed on a straight-line basis and amortized over the shorter of the lease term or the estimated useful lives of the assets.
Concentration of Credit Risk
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, short-term investments and accounts receivable. Cash and cash equivalents and short-term investments are maintained with high quality financial institutions. The Companys accounts receivable are denominated in U.S. dollars and are derived from sales to customers located principally in North America, Europe and Asia. The Company performs ongoing credit evaluations of its customers and generally does not require collateral.
As of October 31, 2004, three customers accounted for 10% or more of the Companys gross accounts receivable. The three customers individually accounted for 13%, 12% and 10% of gross accounts receivable. As of April 30, 2004, one customer accounted for more than 10% of the Companys gross accounts receivable. The one customer accounted for 15% of gross accounts receivable.
Concentration of Other Risks
The semiconductor industry is characterized by rapid technological change, competitive pricing pressures and cyclical market patterns. The Companys financial results are affected by a wide variety of factors, including general economic conditions worldwide, economic conditions specific to the semiconductor industry, the timely implementation of new manufacturing process technologies and the ability to safeguard patents and intellectual property in a rapidly evolving market. In addition, the semiconductor market has historically been cyclical and subject to significant economic downturns at various times. As a result, the Company may experience significant period-to-period fluctuations in operating results due to the factors mentioned above or other factors.
Advertising Costs
Costs related to advertising and promotional expenditures are charged to selling, general and administrative on its consolidated statement of operations. Such advertising and promotional expenditures aggregated to $7,000 and $10,000 for the three months ended October 31, 2004 and 2003, respectively and to $7,000 and $10,000 for the six months ended October 31, 2004 and 2003, respectively
8
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss) includes all changes in equity (net assets) during a period from non-owner sources. Accumulated other comprehensive income (loss) for the Company is comprised of unrealized gains (losses) on securities available-for-sale, net of tax.
Segment Reporting
The Company uses SFAS No. 131, Disclosures about Segments of an Enterprise and Related Information (SFAS 131). SFAS 131 uses the management approach in identifying reportable segments. The management approach designates the internal organization that is used by management for making operating decisions and assessing performance as the source of the companys reportable segments. Based on its operating structure and management reporting, the Company has concluded it has one reporting segment; the semiconductor manufacturing segment.
New Accounting Pronouncements
In March 2004, the FASB approved EITF Issue 03-6, Participating Securities and the Two-Class Method under FAS 128. EITF Issue 03-6 supersedes the guidance in Topic No. D-95, Effect of Participating Convertible Securities on the Computation of Basic Earnings per Share, and requires the use of the two-class method of participating securities. The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In addition, EITF Issue 03-6 addresses other forms of participating securities, including options, warrants, forwards and other contracts to issue an entitys common stock, with the exception of stock-based compensation (unvested options and restricted stock) subject to the provisions of Opinion 25 and SFAS 123. EITF Issue 03-6 is effective for reporting periods beginning after March 31, 2004 and should be applied by restating previously reported earnings per share. The Company adopted EITF Issue 03-6 effective April 30, 2004. The standard had no impact on the Companys reported earnings per share.
Note 3 Net Income Per Share
Basic net income per share is computed by dividing net income available to common stockholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period. Diluted net income per share is computed using the weighted number of common and potentially dilutive common shares outstanding during the period under the treasury stock option method. In computing diluted net income per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options. A reconciliation of the basic and diluted per share computations is as follows (in thousands, except per share data):
| Three Months Ended October 31, |
||||||||||||||||||||||||
| 2004 |
2003 |
|||||||||||||||||||||||
| Per | Per | |||||||||||||||||||||||
| Net | Share | Net | Share | |||||||||||||||||||||
| Income |
Shares |
Amount |
Income |
Shares |
Amount |
|||||||||||||||||||
Basic |
$ | 1,004 | 18,221 | $ | 0.06 | $ | 426 | 16,483 | $ | 0.03 | ||||||||||||||
Effect of stock options |
| 1,757 | (0.01 | ) | | 2,924 | (0.01 | ) | ||||||||||||||||
Diluted |
$ | 1,004 | 19,978 | $ | 0.05 | $ | 426 | 19,407 | $ | 0.02 | ||||||||||||||
Options to purchase 2,013,000 shares of common stock at a weighted average exercise price of $6.79 per share outstanding during the three months ended October 31, 2004 and options to purchase 713,000 shares of common stock at a weighted average exercise price of $6.90 per share outstanding during the quarter ended October 31, 2003 were not included in the computation of diluted income per share because their option price was greater than the average fair market value for the period.
| Six Months Ended October 31, |
||||||||||||||||||||||||
| 2004 |
2003 |
|||||||||||||||||||||||
| Per | Per | |||||||||||||||||||||||
| Net | Share | Net | Share | |||||||||||||||||||||
| Income |
Shares |
Amount |
Income |
Shares |
Amount |
|||||||||||||||||||
Basic |
$ | 3,198 | 17,490 | $ | 0.18 | $ | 1,346 | 16,421 | $ | 0.08 | ||||||||||||||
Effect of stock options |
| 2,004 | (0.02 | ) | | 2,660 | (0.01 | ) | ||||||||||||||||
Diluted |
$ | 3,198 | 19,494 | $ | 0.16 | $ | 1,346 | 19,081 | $ | 0.07 | ||||||||||||||
Options to purchase 1,488,000 shares of common stock at a weighted average exercise price of $6.96 per share outstanding during the six months ended October 31, 2004 and options to purchase 933,000 shares of common stock at a weighted average exercise price
9
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
of $6.44 per share outstanding during the quarter ended October 31, 2003 were not included in the computation of diluted income per share because their option price was greater than the average fair market value for the period.
Note 4 Balance Sheet Components (in thousands):
| October 31, 2004 |
||||||||||||||||
| Gross | Gross | |||||||||||||||
| Unrealized | Unrealized | Estimated | ||||||||||||||
| Cost |
Gains |
(Losses) |
FMV |
|||||||||||||
Investments available-for-sale: |
||||||||||||||||
U.S. government debt securities with maturities less than
one year |
$ | 30,881 | $ | | $ | (46 | ) | $ | 30,835 | |||||||
U.S. government debt securities with maturities over one year |
5,025 | $ | | (16 | ) | 5,009 | ||||||||||
Total investments available-for-sale |
$ | 35,906 | $ | $ | (62 | ) | $ | 35,844 | ||||||||
| April 30, 2004 |
||||||||||||||||
| Gross | Gross | |||||||||||||||
| Unrealized | Unrealized | Estimated | ||||||||||||||
| Cost |
Gains |
(Losses) |
FMV |
|||||||||||||
Investments available-for-sale: |
||||||||||||||||
U.S. government debt securities with maturities less than
one year |
$ | 9,682 | $ | 3 | $ | (6 | ) | $ | 9,679 | |||||||
U.S. government debt securities with maturities over one year |
6,908 | | (23 | ) | 6,885 | |||||||||||
Total investments available-for-sale |
$ | 16,590 | $ | 3 | $ | (29 | ) | $ | 16,564 | |||||||
The financial instruments in short term investments are highly liquid and can be converted to cash and cash equivalents without restriction and, accordingly, are classified as current assets in the accompanying condensed consolidated balance sheets.
| October 31, | April 30, | |||||||
| 2004 |
2004 |
|||||||
Accounts receivable: |
||||||||
Accounts receivable |
$ | 9,699 | $ | 12,685 | ||||
Less: Allowance for doubtful accounts |
(138 | ) | (138 | ) | ||||
| $ | 9,561 | $ | 12,547 | |||||
Inventories: |
||||||||
Work-in-process |
$ | 6,730 | $ | 4,939 | ||||
Finished goods |
3,581 | 2,021 | ||||||
| $ | 10,311 | $ | 6,960 | |||||
Property and equipment: |
||||||||
Engineering and test equipment |
$ | 7,942 | $ | 7,776 | ||||
Computer hardware and software |
2,220 | 1,849 | ||||||
Land and building |
2,124 | | ||||||
Furniture and office equipment |
1,576 | 1,478 | ||||||
| 13,862 | 11,103 | |||||||
Less: accumulated depreciation and amortization |
(8,272 | ) | (7,769 | ) | ||||
| $ | 5,590 | $ | 3,334 | |||||
Accrued expenses: |
||||||||
Accrued employee compensation |
$ | 1,226 | $ | 1,704 | ||||
Accrued income taxes |
1,871 | 1,059 | ||||||
Other |
1,544 | 1,019 | ||||||
| $ | 4,641 | $ | 3,782 | |||||
Note 5 Income Taxes
The provision for income taxes was $216,000, or 17.7% of income before taxes, for the three months ended October 31, 2004 compared to $75,000, or 15% of income before taxes, for the three months ended October 31, 2003. The provision for income taxes was $1.5 million, or 32% of income before taxes, for the six months ended October 31, 2004 compared to $237,000, or 15% of income before taxes, for the six months ended October 31, 2003. In the second quarter of fiscal 2005, the Company revised its estimated tax provision rate from 37% to 32% based on the reinstatement of the federal R&D tax credit and a revised outlook for fiscal 2005.
10
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 6 Stockholders Equity
Common and Preferred Stock
The Company completed a secondary public offering of its common stock in July, 2004. The Company sold 1,450,000 common shares at $6.00 per share. Proceeds to the Company, net of underwriting discounts and commissions and related offering expenses of $713,000 were approximately $8.0 million. In connection with this transaction, Elex N.V., a related party, and other selling stockholders sold 2,850,000 and 300,000 common shares, respectively, at $6.00 per share. In aggregate, 4.6 million common shares were sold.
Note 7 Segment Reporting
The Company operates in one business segment, the semiconductor manufacturing segment. Sales transactions are denominated in U.S. dollars.
Net revenues by product group were as follows (in thousands):
| Three Months Ended October 31, |
Six Months Ended October 31, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
EEPROM |
$ | 13,691 | $ | 14,256 | $ | 27,862 | $ | 26,619 | ||||||||
Flash |
1,368 | 1,483 | 3,142 | &nb | ||||||||||||